logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Feihe International Inc. (06186.HK) spent 87.858 million Hong Kong dollars to repurchase 20 million shares on November 13th.

date
13/11/2025
The app of Wisdom Finance and Economics reports that China Feihe (06186.HK) issued an announcement to repurchase 20 million shares at a cost of 87.858 million Hong Kong dollars on November 13, 2025.
Latest
2 m ago
Chief Financial Officer of Abu Dhabi National Oil Company's natural gas subsidiary: It is expected that by the end of 2026, the benefits brought by the growth in liquefied natural gas demand driven by artificial intelligence will be seen.
2 m ago
Chief Financial Officer of Abu Dhabi National Oil Company Gas says: The use of artificial intelligence is expected to increase net profits.
3 m ago
The International Youth Innovation and Entrepreneurship Program in the Data Industry has been officially launched.
3 m ago
The Monetary Authority of Singapore proposes that financial institutions need to clearly define their responsibility for AI risk management.
3 m ago
Changchun High-tech (000661.SZ) subsidiary GenSci143 obtained approval for overseas production drug registration clinical trial application for injectable drugs.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.